X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs WOCKHARDT LTD. - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA WOCKHARDT LTD. SANOFI INDIA/
WOCKHARDT LTD.
 
P/E (TTM) x 33.3 -15.6 - View Chart
P/BV x 6.3 2.6 248.3% View Chart
Dividend Yield % 1.4 1.3 110.2%  

Financials

 SANOFI INDIA   WOCKHARDT LTD.
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
WOCKHARDT LTD.
Mar-17
SANOFI INDIA/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs4,5601,129 403.9%   
Low Rs4,400627 701.8%   
Sales per share (Unadj.) Rs1,028.5363.1 283.2%  
Earnings per share (Unadj.) Rs129.0-20.4 -630.7%  
Cash flow per share (Unadj.) Rs186.0-7.0 -2,666.3%  
Dividends per share (Unadj.) Rs68.0010.00 680.0%  
Dividend yield (eoy) %1.51.1 133.3%  
Book value per share (Unadj.) Rs753.6301.8 249.7%  
Shares outstanding (eoy) m23.03110.55 20.8%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.42.4 180.2%   
Avg P/E ratio x34.7-42.9 -80.9%  
P/CF ratio (eoy) x24.1-125.9 -19.1%  
Price / Book Value ratio x5.92.9 204.4%  
Dividend payout %52.7-48.9 -107.8%   
Avg Mkt Cap Rs m103,17497,063 106.3%   
No. of employees `0003.66.8 53.5%   
Total wages/salary Rs m3,5929,665 37.2%   
Avg. sales/employee Rs Th6,537.75,931.8 110.2%   
Avg. wages/employee Rs Th991.41,428.1 69.4%   
Avg. net profit/employee Rs Th819.8-334.0 -245.5%   
INCOME DATA
Net Sales Rs m23,68640,146 59.0%  
Other income Rs m7081,143 62.0%   
Total revenues Rs m24,39441,289 59.1%   
Gross profit Rs m5,281128 4,125.8%  
Depreciation Rs m1,3131,489 88.2%   
Interest Rs m152,253 0.7%   
Profit before tax Rs m4,661-2,472 -188.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,691-211 -801.0%   
Profit after tax Rs m2,970-2,260 -131.4%  
Gross profit margin %22.30.3 6,992.9%  
Effective tax rate %36.38.5 424.8%   
Net profit margin %12.5-5.6 -222.7%  
BALANCE SHEET DATA
Current assets Rs m15,67346,160 34.0%   
Current liabilities Rs m6,67819,258 34.7%   
Net working cap to sales %38.067.0 56.7%  
Current ratio x2.32.4 97.9%  
Inventory Days Days76101 75.4%  
Debtors Days Days2294 23.7%  
Net fixed assets Rs m8,09840,165 20.2%   
Share capital Rs m230553 41.7%   
"Free" reserves Rs m17,08832,814 52.1%   
Net worth Rs m17,35633,367 52.0%   
Long term debt Rs m031,903 0.0%   
Total assets Rs m25,40089,687 28.3%  
Interest coverage x311.7-0.1 -320,951.4%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x0.90.4 208.3%   
Return on assets %11.80 -136,882.8%  
Return on equity %17.1-6.8 -252.6%  
Return on capital %26.9-0.3 -8,036.9%  
Exports to sales %24.50-   
Imports to sales %28.00-   
Exports (fob) Rs m5,801NA-   
Imports (cif) Rs m6,627NA-   
Fx inflow Rs m7,1459,121 78.3%   
Fx outflow Rs m6,8462,133 320.9%   
Net fx Rs m2996,988 4.3%   
CASH FLOW
From Operations Rs m3,226-2,695 -119.7%  
From Investments Rs m-1,555-6,863 22.7%  
From Financial Activity Rs m-1,81812,545 -14.5%  
Net Cashflow Rs m-1473,010 -4.9%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 2.3 626.1%  
FIIs % 14.6 7.7 189.6%  
ADR/GDR % 0.0 0.1 -  
Free float % 10.5 15.4 68.2%  
Shareholders   15,184 67,757 22.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   STRIDES SHASUN LTD  AJANTA PHARMA  SUVEN LIFE  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Feb 19, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS